Arkolith/Insider Trading/EMMA/Form 4

Lee Willis C

Co-President & COO, DirectorEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Feb 29, 2024
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 29, 2024Buy(P)77K$0.13$10K159K
Feb 28, 2024Buy(P)15K$0.12$2K82K
Feb 27, 2024Buy(P)10K$0.13$1K67K
Feb 26, 2024Buy(P)13K$0.12$2K57K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-004124) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML